Found: 12
Select item for more details and to access through your institution.
The Combination of Afatinib and Bevacizumab in Untreated EGFR-Mutated Advanced Lung Adenocarcinoma: A Multicenter Observational Study.
- Published in:
- Pharmaceuticals (14248247), 2020, v. 13, n. 11, p. 331, doi. 10.3390/ph13110331
- By:
- Publication type:
- Article
Differential prognostic value of tumor and plasma T790M mutations in EGFR TKI-treated advanced NSCLC.
- Published in:
- Therapeutic Advances in Medical Oncology, 2024, v. 16, p. 1, doi. 10.1177/17588359231222604
- By:
- Publication type:
- Article
Comparison of afatinib and erlotinib combined with bevacizumab in untreated stage IIIB/IV epidermal growth factor receptor-mutated lung adenocarcinoma patients: a multicenter clinical analysis study.
- Published in:
- Therapeutic Advances in Medical Oncology, 2022, p. 1, doi. 10.1177/17588359221113278
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer.
- Published in:
- Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211035710
- By:
- Publication type:
- Article
Afatinib Treatment Alone or with Bevacizumab in a Real-World Cohort of Non-Small Cell Lung Cancer Patients with Epidermal Growth Factor Receptor Mutation.
- Published in:
- Cancers, 2022, v. 14, n. 2, p. 316, doi. 10.3390/cancers14020316
- By:
- Publication type:
- Article
Different Impacts of Traffic-Related Air Pollution on Early-Onset and Late-Onset Asthma.
- Published in:
- Journal of Asthma & Allergy, 2024, v. 17, p. 195, doi. 10.2147/JAA.S451725
- By:
- Publication type:
- Article
Afatinib treatment in a large real‐world cohort of nonsmall cell lung cancer patients with common and uncommon epidermal growth factor receptor mutation.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 4, p. 626, doi. 10.1002/ijc.33821
- By:
- Publication type:
- Article
A retrospective study of alectinib versus ceritinib in patients with advanced non-small-cell lung cancer of anaplastic lymphoma kinase fusion in whom crizotinib treatment failed.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Factors associated with prolonged progression‐free survival of patients treated with first‐line afatinib for advanced epidermal growth factor receptor‐mutated non‐small cell lung cancer.
- Published in:
- Thoracic Cancer, 2024, v. 15, n. 7, p. 529, doi. 10.1111/1759-7714.15212
- By:
- Publication type:
- Article
Influence of chronic obstructive pulmonary disease on long-term hospitalization and mortality in patients with heart failure with reduced ejection fraction.
- Published in:
- BMC Pulmonary Medicine, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12890-023-02357-z
- By:
- Publication type:
- Article
A Real-World Analysis of Patients with Untreated Metastatic Epidermal Growth Factor Receptor (EGFR)-Mutated Lung Adenocarcinoma Receiving First-Line Erlotinib and Bevacizumab Combination Therapy.
- Published in:
- Oncology & Therapy, 2021, v. 9, n. 2, p. 489, doi. 10.1007/s40487-021-00152-6
- By:
- Publication type:
- Article